Correlation Between Cytosorbents Crp and BrainsWay
Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and BrainsWay at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and BrainsWay into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytosorbents Crp and BrainsWay, you can compare the effects of market volatilities on Cytosorbents Crp and BrainsWay and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of BrainsWay. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and BrainsWay.
Diversification Opportunities for Cytosorbents Crp and BrainsWay
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cytosorbents and BrainsWay is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and BrainsWay in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrainsWay and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with BrainsWay. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrainsWay has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and BrainsWay go up and down completely randomly.
Pair Corralation between Cytosorbents Crp and BrainsWay
If you would invest 315.00 in BrainsWay on August 29, 2024 and sell it today you would earn a total of 0.00 from holding BrainsWay or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytosorbents Crp vs. BrainsWay
Performance |
| Timeline |
| Cytosorbents Crp |
| BrainsWay |
Cytosorbents Crp and BrainsWay Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytosorbents Crp and BrainsWay
The main advantage of trading using opposite Cytosorbents Crp and BrainsWay positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, BrainsWay can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrainsWay will offset losses from the drop in BrainsWay's long position.| Cytosorbents Crp vs. LivaNova PLC | Cytosorbents Crp vs. Electromed | Cytosorbents Crp vs. Orthopediatrics Corp | Cytosorbents Crp vs. SurModics |
| BrainsWay vs. Brainsway | BrainsWay vs. Bluejay Diagnostics | BrainsWay vs. Venus Concept | BrainsWay vs. Icecure Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |